TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $272,093 | -99.3% | 32,547 | -98.0% | 0.03% | -99.5% |
Q2 2023 | $41,040,648 | +195331.7% | 1,652,200 | +71985.5% | 6.54% | +217766.7% |
Q1 2022 | $21,000 | -99.4% | 2,292 | -98.9% | 0.00% | -99.5% |
Q4 2021 | $3,787,000 | +15.4% | 199,339 | +102.2% | 0.56% | +144.2% |
Q3 2021 | $3,282,000 | -15.4% | 98,600 | -1.4% | 0.23% | -26.2% |
Q2 2021 | $3,878,000 | -19.5% | 100,000 | 0.0% | 0.31% | +93.2% |
Q1 2021 | $4,820,000 | -7.3% | 100,000 | 0.0% | 0.16% | -29.3% |
Q4 2020 | $5,202,000 | +48.2% | 100,000 | -68.4% | 0.23% | -59.8% |
Q4 2019 | $3,510,000 | – | 316,200 | – | 0.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
Parkwood LLC | 165,414 | $6,081 | 0.66% |
Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |